Literature DB >> 15194792

Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Virginie Sandrin1, Delphine Muriaux, Jean-Luc Darlix, François-Loïc Cosset.   

Abstract

Glycoproteins derived from most retroviruses and from several families of enveloped viruses can form infectious pseudotypes with murine leukemia virus (MLV) and lentiviral core particles, like the MLV envelope glycoproteins (Env) that are incorporated on either virus type. However, coexpression of a given glycoprotein with heterologous core proteins does not always give rise to highly infectious viral particles, and restrictions on pseudotype formation have been reported. To understand the mechanisms that control the recruitment of viral surface glycoproteins on lentiviral and retroviral cores, we exploited the fact that the feline endogenous retrovirus RD114 glycoprotein does not efficiently pseudotype lentiviral cores derived from simian immunodeficiency virus, whereas it is readily incorporated onto MLV particles. Our results indicate that recruitment of glycoproteins by the MLV and lentiviral core proteins occurs in intracellular compartments and not at the cell surface. We found that Env and core protein colocalization in intracytoplasmic vesicles is required for pseudotype formation. By investigating MLV/RD114 Env chimeras, we show that signals in the cytoplasmic tail of either glycoprotein differentially influenced their intracellular localization; that of MLV allows endosomal localization and hence recruitment by both lentiviral and MLV cores. Furthermore, we found that upon membrane binding, MLV core proteins could relocalize Env glycoproteins in late endosomes and allow their incorporation on viral particles. Thus, intracellular colocalization, as well as interactions between Env and core proteins, may influence the recruitment of the glycoprotein onto viral particles and generate infectious pseudotyped viruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194792      PMCID: PMC421692          DOI: 10.1128/JVI.78.13.7153-7164.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Identification of two intracellular mechanisms leading to reduced expression of oncoretrovirus envelope glycoproteins at the cell surface.

Authors:  M P Grange; V Blot; L Delamarre; I Bouchaert; A Rocca; A Dautry-Varsat; M C Dokhélar
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome.

Authors:  Jeffrey N Sfakianos; Eric Hunter
Journal:  Traffic       Date:  2003-10       Impact factor: 6.215

3.  The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter].

Authors:  S Wyss; C Berlioz-Torrent; M Boge; G Blot; S Höning; R Benarous; M Thali
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  The RD114/simian type D retrovirus receptor is a neutral amino acid transporter.

Authors:  J E Rasko; J L Battini; R J Gottschalk; I Mazo; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.

Authors:  D J Wyma; A Kotov; C Aiken
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.

Authors:  D Nègre; P E Mangeot; G Duisit; S Blanchard; P O Vidalain; P Leissner; A J Winter; C Rabourdin-Combe; M Mehtali; P Moullier; J L Darlix; F L Cosset
Journal:  Gene Ther       Date:  2000-10       Impact factor: 5.250

7.  Intracellular interaction of simian immunodeficiency virus Gag and Env proteins.

Authors:  M J Vincent; L R Melsen; A S Martin; R W Compans
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  The Y-S-L-I tyrosine-based motif in the cytoplasmic domain of the human T-cell leukemia virus type 1 envelope is essential for cell-to-cell transmission.

Authors:  L Delamarre; C Pique; A R Rosenberg; V Blot; M P Grange; I Le Blanc; M C Dokhélar
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide.

Authors:  M Li; C Yang; R W Compans
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses.

Authors:  C S Tailor; A Nouri; Y Zhao; Y Takeuchi; D Kabat
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

View more
  34 in total

1.  Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1.

Authors:  Qianting Zhai; Michael B Landesman; Howard Robinson; Wesley I Sundquist; Christopher P Hill
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

2.  Visualization of retrovirus budding with correlated light and electron microscopy.

Authors:  Daniel R Larson; Marc C Johnson; Watt W Webb; Volker M Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

Review 3.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

4.  Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.

Authors:  Andreas Pichlmair; Sandra S Diebold; Stephen Gschmeissner; Yasuhiro Takeuchi; Yasuhiro Ikeda; Mary K Collins; Caetano Reis e Sousa
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

5.  Spontaneous heteromerization of gammaretrovirus envelope proteins: a possible novel mechanism of retrovirus restriction.

Authors:  Marie Dewannieux; Mary K Collins
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

6.  RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.

Authors:  Anna Stornaiuolo; Bianca Maria Piovani; Sergio Bossi; Eleonora Zucchelli; Stefano Corna; Francesca Salvatori; Fulvio Mavilio; Claudio Bordignon; Gian Paolo Rizzardi; Chiara Bovolenta
Journal:  Hum Gene Ther Methods       Date:  2013-08-03       Impact factor: 2.396

7.  Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions.

Authors:  Tareq Jaber; Christopher R Bohl; Gentry L Lewis; Charles Wood; John T West; Robert A Weldon
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

Review 8.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

9.  Targeted cell entry of lentiviral vectors.

Authors:  Sabrina Funke; Andrea Maisner; Michael D Mühlebach; Ulrike Koehl; Manuel Grez; Roberto Cattaneo; Klaus Cichutek; Christian J Buchholz
Journal:  Mol Ther       Date:  2008-06-24       Impact factor: 11.454

10.  Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors.

Authors:  Ilias Christodoulopoulos; Magali E Droniou-Bonzom; Jill E Oldenburg; Paula M Cannon
Journal:  Retrovirology       Date:  2010-01-26       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.